medigraphic.com
ISSN 1995-9427 (Print)

2022, Number 1

<< Back Next >>

Invest Medicoquir 2022; 14 (1)

Chronic autoimmune pancreatitis

Vidal GT

Language: Spanish
References: 77
Page:
PDF size: 248.82 Kb.


ABSTRACT

Autoimmune pancreatitis (AIP) is an uncommon disease, first described 60 years ago, that represents a diagnostic challenge unless it is considered as a cause of acute pancreatitis, pancreatic exocrine insufficiency and a pancreatic mass. Autoimmune pancreatitis is a special form of chronic pancreatitis, more common in men and usually presenting as obstructive jaundice or abdominal pain.This entity is under diagnosed and successful medical therapy is available. We will review the definition, types, clinical manifestations, radiological features, serology, histopathological findings, treatment strategies and diagnostic criteria of autoimmune pancreatitis.


REFERENCES

  1. Sarles H, Sarles JD, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas -An autonomous pancreatic disease? Am J Dig Dis 1961; 6: 688-98.

  2. Aparisi QL. Pancreatitis crónica autoimmune. Rev esp enferm dig 2008; 100(8): 24 – 48.

  3. Oliver PE, Sanz IJ, Fernández EP. Pancreatitis crónica por esclerosis total del páncreas, clínicamente latente y cirrosis biliar de origen extrahepático. Relación de ambos procesos. Rev Esp Enferm Ap Digest Nutric 1961; 20: 287-300.

  4. Sarles H, Adler G, Dani R, Frey C, Gullo L, Harada H. The classification of pancreatitis and definition of pancreatic diseases. Digestion 1989; 43: 34-6.

  5. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by autoimmune abnormality. Proposal of concept of autoimmune pancreatitis. Dig Dis Sci 1995; 40: 1561-68.

  6. Pearson RK, Longnecker DS, Chari ST, Smyrk TC, Okazaki K, Frulloni L,. Controversies in clinical pancreatology: Autoimmune pancreatitis: Does it exist? Pancreas 2003; 27: 1-13.

  7. Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: A variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991; 22: 387-95.

  8. Motoo Y, Minamoto T, Watanabe H, Sakai J, Okai T, Sawabu N. Sclerosing pancreatitis showing rapidly progressive changes with recurrent mass formation. Int J Pancreatol 1997; 21: 85-90.

  9. Ectors N, Maillet B, Aerts R, Geboes K, Donner A, Borchard F. Non-alcoholic duct destructive chronic pancreatitis. Gut 1997; 41: 63-8.

  10. Erkelens GW, Vleggaar FP, Lesterhuis W, van Buuren HR, Van der Werf SD. Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet 1999; 354: 43-4.

  11. Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: Clinicopathologic features of 35 cases. Am J Surg Pathol 2003; 27: 1119-27.

  12. Yadav D, Notahara K, Smyrk T, Clain J, Pearson R, Farnell M,. Idiopathic tumefactive chronic pancreatitis: Clinical profile, histology, and natural history after resection. Clin Gastroenterol Hepatol 2003; 1: 129-35.

  13. Kodama T, Abe M, Sato H, Imamura Y, Koshitani T, Kato K. A case of pseudotumorous pancreatitis that presented unique pancreatoscopic findings with the peroral electronic pancreatoscope. J Gastroenterol Hepatol 2003; 18: 108-11.

  14. Kamisawa T, Okamoto A. Autoimmune pancreatitis: Proposal of IgG4-related sclerosing disease. J Gastroenterol 2006; 41: 613-15.

  15. Cai O, Tan S. From pathogenesis, clinical manifestation and diagnosis to treatment: an overview on autoimmune pancreatitis. Gastroenterol Res Pract 2017; 32: 46 – 59.

  16. Majumder S, Takahashi N, Chari ST. Autoimmune pancreatitis. Dig Dis Sci 2019 ; 62(7): 1762 – 69.

  17. Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Zhang L. Diagnosis of autoimmune pancreatitis: The Mayo Clinic experience. Clin Gastroenterol Hepatol 2006; 4: 1010-6.

  18. Hart PA, Zen y, Chari ST. Recent advances in autoimmune pancreatitis. Gastroenterology 2015; 149: 39-51.

  19. Watanabe T, Minaga K, Kamata K, Kudo Masatoshi, Strober W. Mechanistic insights into autoimmune pancreatitis and IgG4-related disease. Trends in immunology 2018 Nov; 39(11): 874-89.

  20. Berger Z, Mancilla AC. Enfermedad relacionada a IgG4: manifestaciones extrapancreáticas en pancreatitis autoimmune. Rev Med Chile 2016; 142(10): 15 – 118.

  21. Madhani K, Felker S, Felker ER. Evaluation of international consensus diagnostic criteria in the diagnosis of autoimmune pancreatitis: a single center North American Cohort Study. JOP 2017; 18(4): 327- 34.

  22. Kamisawa T. IgG4-positive plasma cells specifically infiltrate various organs in autoinmmune pancreatitis. Pancreas 2015; 29: 167-8.

  23. Muñoz CS, Mancilla AC, Moyano SL, Castillo TC, Rossi RF, Brahm BJ, et al. Pancreatitis autoinmune: experiencia clínica y revision de la literatura. Rev Med Chile 2016; 138: 295 – 302.

  24. Frulloni L, Bovo P, Brunelli S, Vaona B, Di Francesco V, Nishimori I, et al. Elevated serum levels of antibodies to carbonic anhydrase I and II in patients with chronic pancreatitis. Pancreas 2014; 20: 382-8.

  25. Nishimori I, Yamamoto Y, Okazaki K, Morita M, Onodera M, Kino J, et al. Identification of autoantibodies to a pancreatic antigen in patients whit idiopathic pancreatitis and Sjögren's syndrome. Pancreas 1994; 9: 374-81.

  26. Nishimori I, Miyaji E, Morimoto K, Nagao K, Kamada M, Onishi S. Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis. Gut 2015; 54: 274-81.

  27. Kino-OJ, Nishimori I, Morita M, Okazaki K, Yamamoto Y, et al. Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjögren's syndrome. Gastroenterology 2006; 110: 1579-86.

  28. Aparisi L, Farré A, Gómez-Cambronero L, Martínez J, de las Heras G, Corts J, et al. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: Relevance for diagnosis of autoimmune pancreatitis. Gut 2005; 54: 703-9.

  29. . Okazaki K, Uchida K, Ohana M, Nakase H, Uose S, Inai M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th -type cellular immune response. Gastroenterology 2010; 118: 573-81.

  30. Uchida K, Okazaki K, Nishi T, Uose S, Nakase H, Ohana M, et al. Experimental immune-mediated pancreatitis in neonatally thymectomized mice immunized with carbonic anhydrase II and lactoferrin. Lab Invest 2012; 82 : 411-24.

  31. Madhani K, Farrell JJ. Autoimmune pancreatitis: an update on diagnosis and management. Gastroenterol Clin North Am 2016; 45(1): 29 – 43.

  32. Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis. N Engl J Med 2006; 355: 2670-6.

  33. . Kawa S, Ota M, Yoshizawa K, Horiuchi A, Hamano H, Ochi Y, et al. HLA DRB1*0405-DQB1 Haplotype is associated with autoimmune pancreatitis in Japanese population. Gastroenterology 2012; 122: 1264-9.

  34. Kim KP, Kim MH, Song MH, Lee SS, Seo DW, Lee SK. Autoimmune chronic pancreatitis. Am J Gastroenterol 2014; 99: 1605-16.

  35. Okazaki K. Autoimmune pancreatitis is increasing in Japan. Gastroenterology 2013; 125: 1557-8.

  36. Uchida K, Okazaki K, Konishi Y, Ohana M, Takakuwa H, Hajiro K, et al. Clinical analysis of autoimmune-related pancreatitis. Am J Gastroenterol 2016; 95: 2788-94.

  37. Ghazale A, Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2017; 102: 1646-53.

  38. . Zamboni G, Lüttges J, Capelli P, Frulloni L, Cavallini G, Pederzoli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: A study on 53 resection specimens and 9 biopsy specimens. Virchow Arch 2004; 445: 552-63.

  39. Donet JA, Czul F, Peña NA, Barkin JS. Pancreatitis autoimmune tipo 1: caso y revisión de la enfermedad. Rev Gastroenterol Peru 2016; 36(3): 252 – 5.

  40. Scheers I, Palermo JJ, Freedman S. Autoimmune pancreatitis in children: characteristic features, diagnosis and management. Am J Gastroenterol 2017; 112(10): 1604 – 11.

  41. Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A, Kamata N. Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinoma. Am J Gastroenterol 2013; 98: 2694-9.

  42. Lorenzo D, Maire F, Stefanescu C, Gornet JM, Seksik P, Serrero M, et al. Features of autoimmune pancreatitis associated with inflammatory bowel disease. Clinical Gastroenterology and Hepatology 2018; 16: 59-67.

  43. Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol 2006; 41: 1197-05.

  44. Ito T, Kawabe K, Arita Y, Hisano T, Igarashi H, Funakoshi A, et al. Evaluation of pancreatic endocrine and exocrine function in patients with autoimmune pancreatitis. Pancreas 2017; 34: 254-9.

  45. De las Heras CG, Castro SB, García SC, López HM, San SD, Juanco C, et al. Pancreatitis autoinmune. ¿Una entidad poco frecuente o infradiagnosticada?. Características anatomopatológicas, clínicas e inmunológicas. Gastroenterol Hepatol 2016; 29: 299-305.

  46. Nishimori I, Tamakoshi A, Kawa S, Tanaka S, Takeuchi K, Kamisawa T, et al. Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: Findings from a nationwide survey in Japan. Pancreas 2016; 32: 244-8.

  47. Kanno A, masamune A, Okasaki K. nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011. Pancreas 2015; 44: 535 – 39.

  48. Okasaki K, Chari ST, Frulloni L. International consensus for the treatment of autoimmune pancreatitis. Pancreatology 2017; 17(1): 1 – 6.

  49. Okazaki K, Uchida K, Ohana M, Nakase H, Uose S, Inai M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th -type cellular immune response. Gastroenterology 2017; 118: 573-81.

  50. Hirano K, Kawabe T, Yamamoto N, Nakai Y, Sasahira N, Tsujino T, et al. Serum IgG4 concentrations in pancreatic and biliary diseases. Clin Chim Acta 2016; 367: 181-4.

  51. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344: 732-8.

  52. . Kim KP, Kim MH, Kim JC, Lee SS, Seo DW, Lee SK. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol 2006; 12: 2487-96.

  53. Okazaki K, Kawa S, Kamisawa T, Naruse S, Tanaka S, Nishimori I, et al. Clinical diagnostic criteria of autoimmune pancreatitis: Revised proposal. J Gastroenterol 2006; 41: 626-31.

  54. Berger Z. Un desafío clínico: diagnóstico diferencial de pancreatitis autoinmune y cáncer de pancreas. El valor del tratamiento esteroidal de prueba. Rev Med Chile 2014; 142 (4): 110 – 18.

  55. Horiuchi A, Kawa S, Hamano H, Hayama M, Ota H, Kiyosawa K. ERCP features in 7 patients with autoimmune pancreatitis. Gastrointest Endosc 2012; 55: 494-9.

  56. Wakabayashi T, Kawaura Y, Satomura Y, Watanabe H, Motoo Y, Okai T, et al. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: Comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma. Am J Gastroenterol 2013; 98: 2679-87.

  57. Villalobos SA, Muñoz MA, Perez de Pedro I, Navarro PA, Reguera IJ, Gomez HR. Pancreatitis autoimmune. A propósito de un caso. An Med Int 2018; 25(7): 31- 8.

  58. Dong Y, D'Onofrio M, Hucke M. Autoimmune pancreatitis: imaging features. Endosc Ultrasound 2017; 7(3): 196 – 203.

  59. Sahani DV, Kalva SP, Farrell J, Maher MM, Saini S, Mueller PR, et al. Autoimmune pancreatitis: Imaging features. Radiology 2014; 233: 345-52.

  60. Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A, Akuni L, et al Morphological changes after steroid therapy in autoimmune pancreatitis. Scand J Gastroenterol 2014; 39: 1154-8.

  61. Kamisawa T, Chen P, NakajimaY , Egawa N, Tsuruta K, Okamoto A, et al. Pancreatic cancer with a high serum IgG4 concentration. World J Gastroenterol 2016; 12:6225-8.

  62. Hart PA, Levy MJ, Smyrk TC, Takahashi N, Abu BK, Clain JE, et al.Clinical profiles and outcomes in idiopathic duct – centric chronic pancreatitis ( type 2 autoimmune pancreatitis) : the Mayo Clinic experience.GUT 2019 ; 65 (10) 1702 – 9.

  63. Kamisawa T, Chen PY, Tu Y, Nakajima H, Egawa N, Tsuruta K, et al. MRCP and MRI findings in 9 patients with autoimmune pancreatitis. World J Gastroenterol 2016; 12 (18): 2919-22.

  64. Ohara H, Nakazawa T, Ando T, Joh T. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. J Gastroenterol 2017; 42 (18): 15-21.

  65. Kamisawa T, Chen PY, Tu Y, Nakajima H, Egawa N. Autoimmune pancreatitis metachronously associated with retroperitoneal fibrosis with IgG4-positive plasma cell infiltration. World J Gastroenterol 2016; 12: 2955-7.

  66. . Kamisawa T, Funata N, Hayashi Y, Tsuruta T, Okamoto A, Amemiya K, et al. Close relationship between autoimmune pancreatitis and multifocal fibroesclerosis. Gut 2013; 52: 683-7.

  67. Madhany K, Farrell JJ. Management of autoimmune pancreatitis. Gastrointest Endoscopy Clin N AM 2018 ; 28 : 493-519.

  68. Nishimori I, Kikuta K, Tsuji I, Mizuni N, Iiyama T, Kanno A, et al. Randomised controlled trial of long term maintenance corticosteroid therapy in patients with autoimmune pancreatitis.GUT 2019 ; 66 (3) : 487-94.

  69. Okazaki K, Autoimmune pancreatitis and IgG4- related disease: the storiform discovery to treatment. Dig Dis Sci 2019 ; 64(9) : 2385- 994.

  70. Masamune A, Nishimuri I, Kikuta K. Randomised controlled trial of long-term maintenance corticosteroid therapy in patient with autoimmune pancreatitis. GUT 2017; 66(3):487-94.

  71. Frulloni L, de Pretis N, Amadio A. Maintenance therapy in autoimmune pancreatitis: a weak light into the darkness. Ann Transl Med 2017; 5(17): 367 – 73.

  72. Hirano K, Tada M, Isayama H. Outcome of long-term maintenance steroid therapy cessation in patients with autoimmune pancreatitis: a prospective study. J Clinic Gastroenterol 2016; 50(4): 331 – 37.

  73. Members of the Criteria Committee for Autoimmune Pancreatitis of the Japan Pancreas Society. Diagnostic criteria for autoimmune pancreatitis by the Japan Pancreas Society. J Jpn Pan Soc 2002; 17: 585-7.

  74. Kubota K, Kamisawa T, Hirano K. Clinical course of type 1 autoimmune pancreatitis patients without steroid treatment: a Japanese multicenter study of 97 patients. J Hepatobiliary Pancreat Sci 2018; 25(4): 223 – 30.

  75. Hart PA, Chari ST. Preventing disease relapses in autoimmune pancreatitis with maintenance steroids: are we there yet? GUT 2017; 66(3): 394 – 96.

  76. Kamisawa T, Chung JB, Irie H, Nishino T, Ueki T, Takase M, et al. Japan-Korea symposium on autoimmune pancreatitis (KOKURA 2007). Pancreas 2007; 35: 281-4.

  77. Hirano K, Tada M, Isayama H, Yagioka H, Sasaki T, Kogure H, et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut 2017; 56: 1719-4.




2020     |     www.medigraphic.com